Partnerships & Mergers

Under the agreement, both organizations will conduct a series of early screening campaigns across Caritas Egypt’s network of branches.

The partnership reflects Upwyde Developments’ vision of creating smart, mixed-use destinations that integrate residential, commercial, administrative, and medical services in one location.

The Rembra platform extends the use of computed tomography beyond traditional diagnostic radiology into radiation therapy planning.

By integrating Aicuris into its global development and commercialization infrastructure, Asahi Kasei accelerates its expansion in the specialty pharmaceutical sector.

The therapy, known as NRTX-1001, uses pluripotent stem cells engineered to regulate brain activity and repair damaged neural networks.

The partnership leverages the EAEA’s scientific expertise with Alameda Healthcare’s clinical and operational capabilities to create a sustainable, patient-centered treatment hub.

The collaboration leverages JW Pharmaceutical’s established research and development capabilities to accelerate the drug’s entry into South Korea’s growing metabolic disease sector.

Through this agreement, Gilead now controls global rights to KT-200, an oral CDK2 molecular glue degrader designed to treat cancer.

AVS has developed the Pulse IVL system, which uses pressurised sound waves delivered through a balloon catheter to remove calcium deposits in patients with calcified peripheral artery disease (PAD).

The company receives USD10 million in near-term milestones and stands to earn up to USD 705 million additional milestone payments upon reaching key development and regulatory benchmarks.